SCHEMBL7679192

SCHEMBL7679192

Cc1nc(N2CCOCC2)ccc1C(N)=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 4/20 0.47
PIK3C2B O00750 4/20 0.47
MTOR P42345 3/20 0.47
PIK3CG P48736 3/20 0.47
GAA P10253 3/20 0.46
ALDH1A1 P00352 3/20 0.46
KDM4E B2RXH2 2/20 0.46
IKBKB O14920 1/20 0.45
NNMT P40261 1/20 0.45
HTT P42858 1/20 0.45
CRHBP P24387 1/20 0.43
CRHR2 Q13324 1/20 0.43
AURKA O14965 1/20 0.43
RPS6KB1 P23443 1/20 0.43
IRAK4 Q9NWZ3 1/20 0.43
HPGD P15428 1/20 0.43
ALOX15 P16050 1/20 0.43
TSHR P16473 1/20 0.43
CASP1 P29466 1/20 0.43
CASP7 P55210 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2130484 0.87 PKM (0.53) PIK3CDPIK3C2BMTORPIK3CGGAA
SCHEMBL30572211 0.82 NNMT (0.45) PIK3CDPIK3C2BMTORPIK3CGGAA
SCHEMBL30572289 0.82 IKBKB (0.45) ALDH1A1KDM4EIKBKBNNMTHTT
SCHEMBL10169396 0.82 BTK (0.49) PIK3CDPIK3C2BMTORPIK3CGGAA
SCHEMBL30590396 0.77 PRKDC (0.50) GAAALDH1A1KDM4ECRHBPCRHR2
SCHEMBL1912050 0.76 CRHBP (0.53) PIK3CDPIK3C2BMTORPIK3CGGAA
SCHEMBL2134143 0.76 NNMT (0.40) NNMTHPGDBTK
SCHEMBL17531163 0.76 ALDH1A1 (0.50) GAAALDH1A1KDM4EHTTCRHBP
SCHEMBL3095284 0.75 IKBKB (0.56) GAAALDH1A1KDM4EIKBKBHTT
SCHEMBL2254866 0.75 GAA (0.43) GAAALDH1A1KDM4EHTTCRHBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6407111-B1 SUBSTANCE P OR NEUROKININ 1 ANTAGONISTS; ANTIINFLAMMATORY, ANTIDEPRESSANT, ANTIARTHRITIC, AND ANTIASTHMATIC AGENTS; PARKINSON*S DISEASE, INFLAMMATORY BOWEL DISEASE, CENTRAL NERVOUS SYSTEM AND RHEUMATIC DISORDERS HOFFMANN-LA ROCHE INC. 2002-06-18 US disclosed